Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0003-0900-0923Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Javier Leo, Feiyu Chen, Wei Shi…·Di Zhao
This study shows that TP53-deficient tumors resist DS-7300a therapy, but inducing ferroptosis can enhance its efficacy in these cancers.
Michael J. Schmidt, Amin Naghdloo, Rishvanth K. Prabakar…·James B Hicks
The paper identifies polyploid cancer cells as markers of chemotherapy resistance and recurrence in prostate cancer, linking them to poorer survival outcomes.
Yujie Jiang, Matthew D. Montierth, Kaixian Yu…·Wenyi Wang
The paper develops CliPP to estimate subclonal mutation load (sML) and shows it predicts survival and immunotherapy response in cancers with low to moderate TMB.
Shuai Guo, Xiaoqian Liu, Xuesen Cheng…·Wenyi Wang
DeMixSC improves deconvolution accuracy by using single-cell RNA-seq and a benchmark dataset to account for technological discrepancies in complex tissue samples.